Abstract: The present invention provides a method of enhancing an immune response to a vaccine by administering a vaccine and a population of isolated allogeneic human mesenchymal stem cells. The present invention also provides kits comprising a vaccine in a first container and a population of isolated allogeneic human mesenchymal stem cells in a second container.

Abstract: This invention is directed to optical cable components fabricated from an extrudable blend of high crystalline polypropylene and an impact modifying polymer to provide an enhanced balance flexural modulus, Izod notched value, grease resistance, and low shrinkage properties. The polypropylene has a crystallinity of greater than weight percent and a melt flow of from 1 to 20 grams per 10 minutes at 230 degrees C. At 23 degrees C., the composition yields an extrudant having a 1-percent secant modulus of at least 1,600 MPa and a notched Izod of at least 35 J/m. The composition also yields an extruded tube having a shrinkage of less than 2.0 percent after 24 hours at 100 degrees C.

Abstract: The invention is directed to a polypropylene resin which has a Mw/Mn of less than 5, a melt flow rate of less than 7 g/10 min., a 1% secant flexural modulus of greater 5 than 300,000 psi and less than 2 wt. % xylene solubles.